Cargando…

427. Trends in Hospital-onset Escherichia coli Infections Resistant to Fluoroquinolones and Extended-spectrum Cephalosporins, 2012-2020

BACKGROUND: Inpatient and outpatient fluoroquinolone (FQ) use has decreased substantially in the last decade; however, the impact of this trend on FQ resistance is less clear. During this period, extended-spectrum β-lactamase (ESBL) Escherichia coli infections have increased. We examined hospital-on...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hood, Nicole, Wolford, Hannah, Olubajo, Babatunde, Rose, Ashley, Baggs, James, Reddy, Sujan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9751742/ http://dx.doi.org/10.1093/ofid/ofac492.502

Ejemplares similares

2479. Trends and Regional Differences in Extended Spectrum β-lactamase (ESBL)-producing Enterobacteriaceae, 2012–2017
por: Wolford, Hannah, et al.
Publicado: (2019)

845. Trends and Regional Differences in Community-Onset Fluoroquinolone-Resistant E. coli in Hospitalized Adults in the United States
por: Wolford, Hannah, et al.
Publicado: (2020)

Temporal trends in urine-culture rates in the US acute-care hospitals, 2017–2020
por: Kazakova, Sophia, et al.
Publicado: (2022)

121. Temporal Trends in Urine Culture Rates in the U.S. Acute Care Hospitals During 2012–2017
por: Kazakova, Sophia, et al.
Publicado: (2020)

1686. Microbiology of Community-Onset Urinary Tract Infections in the United States, 2012-2017
por: Preston, Leigh Ellyn, et al.
Publicado: (2020)

545. Incidence of Carbapenem Non-Susceptible Acinetobacter spp. and Carbapenem-Resistant Pseudomonas aeruginosa Clinical Cultures among Patients in US Acute Care Hospitals, 2012–2017
por: Kazakova, Sophia, et al.
Publicado: (2019)

2455. National Trends in the Rates of Drug-resistant Bacteria Commonly Associated with Healthcare in U.S. Acute Care Hospitals, 2019-2021
por: Baggs, James, et al.
Publicado: (2023)

916. National Estimates of the Proportion of Bacterial Pathogens Expressing Resistant Phenotypes in US Hospitals, 2012-2017
por: Baggs, James, et al.
Publicado: (2020)

2850. Burden of Difficult-to-Treat Antibiotic-Resistant (DTR) Gram-Negative Infections in the United States, 2012–2017
por: Kadri, Sameer S, et al.
Publicado: (2019)

2472. Hospital Onset Antibiotic Resistant Infections among Patients without COVID-19 Diagnosis in Pre-Pandemic and Pandemic Periods
por: Baggs, James, et al.
Publicado: (2023)

1428. The proportion of excess hospital-onset antibiotic-resistant infections attributable to patients diagnosed with COVID-19 in U.S. hospitals, 2019-2021
por: Wolford, Hannah, et al.
Publicado: (2023)

Fluconazole resistance in non-albicans Candida species in the United States, 2012-2021
por: Jenkins, Emily, et al.
Publicado: (2023)

Genetic Determinants of Resistance to Extended-Spectrum Cephalosporin and Fluoroquinolone in Escherichia coli Isolated from Diseased Pigs in the United States
por: Hayer, Shivdeep Singh, et al.
Publicado: (2020)

Empiric antibiotic selection for community-acquired pneumonia in US hospitals, 2013–2020
por: Wolford, Hannah, et al.
Publicado: (2023)

Genomic Epidemiology of Gonococcal Resistance to Extended-Spectrum Cephalosporins, Macrolides, and Fluoroquinolones in the United States, 2000–2013
por: Grad, Yonatan H., et al.
Publicado: (2016)

2463. Increased Rates of Candida Bloodstream Infections Associated with Drug Use, United States 2012–2017
por: McCarthy, Natalie, et al.
Publicado: (2019)

Resistance to extended-spectrum cephalosporins in Escherichia coli and other Enterobacterales from Canadian turkeys
por: Moffat, Jonathan, et al.
Publicado: (2020)

Molecular characterization of extended-spectrum cephalosporin and fluoroquinolone resistance genes in Salmonella and Shigella isolated from clinical specimens in Thailand
por: Sriyapai, Thayat, et al.
Publicado: (2022)

Fluoroquinolones Protective against Cephalosporin Resistance in Gram-negative Nosocomial Pathogens
por: Schwaber, Mitchell J., et al.
Publicado: (2004)

A retrospective review of oral cephalosporins versus fluoroquinolones for the treatment of pyelonephritis
por: Lin, Kevin, et al.
Publicado: (2022)

Rapid evolution of fluoroquinolone-resistant Escherichia coli in Nigeria is temporally associated with fluoroquinolone use
por: Lamikanra, Adebayo, et al.
Publicado: (2011)

Dynamics of extended-spectrum cephalosporin resistance genes in Escherichia coli from Europe and North America
por: Zamudio, Roxana, et al.
Publicado: (2022)

2473. Rates of Antibiotic Resistant Infections in Hospitalized Patients with Hematologic and Non-Hematologic Cancers, 2019
por: McCarthy, Natalie, et al.
Publicado: (2023)

427. Putting the ‘Eye’ in Spirochetes
por: Khalil, Sarwat, et al.
Publicado: (2019)

Molecular characterization of fluoroquinolone and/or cephalosporin resistance in Shigella sonnei isolates from yaks
por: Zhu, Zhen, et al.
Publicado: (2018)

Emergence of Resistance to Fluoroquinolones and Third-Generation Cephalosporins in Salmonella Typhi in Lahore, Pakistan
por: Rasheed, Farhan, et al.
Publicado: (2020)

1459. Oral Cephalosporins vs. Fluoroquinolones for the Empiric Treatment of Acute Uncomplicated Pyelonephritis
por: Lin, Kevin, et al.
Publicado: (2019)

Effect of Reduced Fluoroquinolone Use on Cephalosporin Use, Susceptibilities and Clostridioides difficile Infections
por: Wren, Callyn Mariah, et al.
Publicado: (2022)

2094. Acceptability of Antibiotic Substitutions for Fluoroquinolones and Third and Fourth-generation Cephalosporins: A Report from the VA-CDC Practice-Based Research Network (PBRN)
por: Goetz, Matthew B, et al.
Publicado: (2019)

Association of Hospital-Onset Clostridium difficile Infection Rates and Antibiotic Use in US Acute Care Hospitals, 2006–2012: An Ecologic Analysis
por: Kazakova, Sophia, et al.
Publicado: (2017)

Length of antibiotic therapy among adults aged ≥65 years hospitalized with uncomplicated community-acquired pneumonia, 2013-2020
por: McCarthy, Natalie, et al.
Publicado: (2023)

Assessment of Hospital-Onset SARS-CoV-2 Infection Rates and Testing Practices in the US, 2020-2022
por: Hatfield, Kelly M., et al.
Publicado: (2023)

Association of Veterinary Third-Generation Cephalosporin Use with the Risk of Emergence of Extended-Spectrum-Cephalosporin Resistance in Escherichia coli from Dairy Cattle in Japan
por: Sato, Toyotaka, et al.
Publicado: (2014)

Characterization of extended-spectrum cephalosporins and fluoroquinolone resistance of a Salmonella enterica serovar Thompson isolate from ready-to-eat pork product in China
por: Li, Lili, et al.
Publicado: (2022)

427 AEROSOL MODELING AND MITIGATION STRATEGIES
por: Jaruvongvanich, Veeravich, et al.
Publicado: (2021)

Transfer Potential of Plasmids Conferring Extended-Spectrum-Cephalosporin Resistance in Escherichia coli from Poultry
por: Mo, Solveig Sølverød, et al.
Publicado: (2017)

Temporal dynamics of genetically heterogeneous extended-spectrum cephalosporin-resistant Escherichia coli bloodstream infections
por: Shropshire, William C., et al.
Publicado: (2023)

24. Antibiotic Use in Hospital Emergency Departments and Observation Settings from 2012–2018 in a Large Cohort of U.S. Hospitals
por: Preston, Leigh Ellyn, et al.
Publicado: (2020)

Associations of facility-level antibiotic use and hospital-onset Clostridioides difficile infection in US acute-care hospitals, 2012–2018
por: Kazakova, Sophia V., et al.
Publicado: (2022)

The Value of Fortified Aminoglycoside/Cephalosporin Treatment as First-Line Treatment and in Fluoroquinolone-Resistant Bacterial Keratitis
por: Dikmetaş, Özlem, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_gs9s6243va6njdhd7tl38mibnq